Biotech Analyst, Seligman Investments

About Our Company Working at Columbia Threadneedle Investments you'll find growth and career opportunities across all of our businesses.We're intentionally built to help you succeed. Our reach is expansive with a Columbia Threadneedle Investments global team of 2,300 people working together. Our capability is diverse with more than 550 investment professionals sharing global perspectives across all major asset classes and markets. Our clients have access to a broad array of investment strategies, and we have the capability to create bespoke solutions matched to clients' specific requirements. Our unwavering focus on our clients and strong financial foundation connects each of our enterprise businesses - Ameriprise Financial, Columbia Threadneedle Investments and RiverSource Insurance and Annuities.Job DescriptionThe Biotech / Pharmaceutical Analyst position is a key member of the Healthcare Fund at Seligman Investments, part of Columbia Threadneedle Investments, an asset manager with over $654 billion in assets under management. This is a unique opportunity to join a growing fund with an entrepreneurial spirit integrated in a highly established and reputable investment firm / platform.Key Responsibilities * Biotech and pharmaceutical public equity coverage and research of both commercial and development stage drug candidates. * Conduct rigorous scientific, clinical, statistical, manufacturing, patent, regulatory due diligence - quickly distilling what information may impact investment thesis. * Generate investment recommendations: thesis, risk-reward, supporting evidence, and catalysts. * Build and maintain therapeutic class, disease area, regulatory precedents databases. * Drive valuation conclusions through revenue builds, financial models, comp sheets. * Continually refine thesis and research processes. * Communicate effectively research and new developments in a timely manner. * Strong work ethic, high integrity, drive for results, entrepreneurial spirit, intellectual curiosity and honesty contributing to a positive culture and team environment.Required Qualifications * 5+ years in the biotechnology/ pharmaceutical sector either in clinical, scientific, financial services, or industry capacity. * 2+ years of experience as a buyside investment analyst covering biotech/ pharmaceuticals. * Proven ability to interpret clinical and scientific data and translating findings into investment implications and recommendations. * Strong financial modeling, valuation, and analytical abilities. Preferred Qualifications * Experience with private investments and derivatives. * Experience with advanced data analysis/ coding/ modeling. * Advanced degree (Doctorate/ Masters).Visa Sponsorship:Applicants must have a valid work authorization that does not now, or in the future, require visa sponsorship for employment in the United States (e.g., H-1B, F-1 CPT, F-1 OPT, TN). In-Office Collaboration:We are a client-centric, relationship-based business. Working together, in-person, is foundational to how we achieve results. By fostering a culture of face-to-face collaboration, idea sharing, productivity and personal connection, we deliver for our stakeholders - clients, advisors, employees and shareholders. Our employees work in the office at least four (4) days per week, with flexibility to work from home one (1) day per week. Some roles may require additional in-office time or different in-office expectations, and specific requirements will be discussed during the hiring process.Base Pay SalaryThe estimated base salary for this role is $190,000 - $250,000 per year. We have a pay-for-performance compensation philosophy. Your initial total compensation may vary based on job-related knowledge, skills, experience, and geographical work location. In addition, most of our roles are eligible for variable pay in the form of bonus, commissions, and/or long-term incentives dep